Vendor review
Peptide Crafters is graded B+ (82/100). It passed the trust floor (a score of at least 70 with testing, transparency and catalog data all observed), so its offers can be picks. We track 33 offers from Peptide Crafters. Prices last checked Nov 14, 2026; that check returned no current prices, so the newest prices on record are from Nov 1, 2026.
Prices checked · Picks as of · Grade evidence cutoff
Price position
Cheaper than the median on 19 of 32 products that other tracked vendors also sell; above it on 9 and at it on 4. 1 other product has no other tracked offer. Prices are effective single-package prices; the median covers every tracked offer for the same product.
| Product | Peptide Crafters price | Median of tracked offers | Position | Pick |
|---|---|---|---|---|
| ARA-290 16 mg vial | $50 | $69.484 offers | 28% below the median | |
| BPC-157 10 mg vial | $50 | $49.9929 offers | Just above the median | |
| Cagrilintide 10 mg vial | $95 | $89.9921 offers | 6% above the median | |
| Cardiogen 25 mg vial | $55 | $572 offers | 4% below the median | |
| CJC-1295 5 mg vial | $30 | $3919 offers | 23% below the median | |
| DSIP 5 mg vial | $30 | $37.9925 offers | 21% below the median | |
| GHK-Cu 100 mg vial | $45 | $5430 offers | 17% below the median | |
| Glutathione 1500 mg vial | $80out of stock when checked | $6521 offers | 23% above the median | |
| IGF-1 LR3 1 mg vial | $65 | $6729 offers | 3% below the median | |
| Ipamorelin 10 mg vial | $50 | $5030 offers | At the median | |
| Kisspeptin-10 5 mg vial | $30 | $52.505 offers | 43% below the median | |
| KPV 10 mg vial | $40 | $5034 offers | 20% below the median | |
| Melanotan I 10 mg vial | $30 | $39.9921 offers | 25% below the median | |
| Melanotan II 10 mg vial | $30 | $3537 offers | 14% below the median | |
| NAD+ 1000 mg vial | $85 | $99.9911 offers | 15% below the median | |
| Oxytocin 5 mg vial | $45out of stock when checked | $297 offers | 55% above the median | |
| PT-141 (Bremelanotide) 10 mg vial | $35 | $4039 offers | 13% below the median | |
| Retatrutide 10 mg vial | $70 | $69.5010 offers | 1% above the median | |
| Retatrutide 20 mg vial | $150 | $104.998 offers | 43% above the median | |
| Retatrutide 30 mg vial | $180 | $1826 offers | 1% below the median | |
| Retatrutide 60 mg vial | $280out of stock when checked | $337.504 offers | 17% below the median | |
| Selank 10 mg vial | $35 | $40.9034 offers | 14% below the median | |
| Semaglutide 10 mg vial | $80 | $63.209 offers | 27% above the median | |
| Semaglutide 20 mg vial | $115 | $1155 offers | At the median | |
| Semaglutide 5 mg vial | $50 | $508 offers | At the median | |
| Semax 10 mg vial | $35 | $40.4028 offers | 13% below the median | |
| Sermorelin 10 mg vial | $55 | $64.5022 offers | 15% below the median | |
| SNAP-8 10 mg vial | $30 | $3520 offers | 14% below the median | |
| TB-500 10 mg vial | $60 | $5534 offers | 9% above the median | |
| Tesamorelin 10 mg vial | $55 | $6527 offers | 15% below the median | |
| Tesamorelin/Ipamorelin Blend 14 mg vial | $80 | None1 offer | Only tracked offer | |
| Thymosin Alpha-1 10 mg vial | $65 | $6530 offers | At the median | |
| VIP (Vasoactive Intestinal Peptide) 10 mg vial | $75 | $5914 offers | 27% above the median |
Picks won
No picks as of Nov 14, 2026: none of its offers met every pick rule.
Testing record
Of 33 tracked products: 6 with a lab-verified COA, 26 with a product COA on file and 1 with only COAs for other products. 1138 public COAs from Peptide Crafters are archived; the newest was tested Aug 26, 2026. Labs named on COAs for its tracked products: Accumark Labs, Janoshik Analytical, Pharmetric Laboratory and Vanguard Laboratory.
A COA describes the batch it names. It does not show which lot a vendor ships today, and PepGrades does not ask vendors to say.
Deals
No automatic deal from Peptide Crafters is on record.
Transparency checklist
6 of 8 public pages were found when the grade was built (evidence cutoff Sep 12, 2026). A page found is not a review of its terms; shipping fees, delivery times and refund terms are not recorded.
Grade
B+ (82/100) from the components below, with evidence up to Sep 12, 2026. Price updates do not change the grade; public discussion is not scored.